HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,940,000 | -57.2% | 49,397 | -43.6% | 0.54% | -48.3% |
| Q1 2022 | $9,207,000 | +208.6% | 87,512 | +216.1% | 1.03% | +139.4% |
| Q4 2021 | $2,983,000 | -4.9% | 27,685 | -3.4% | 0.43% | -6.7% |
| Q3 2021 | $3,138,000 | +17.0% | 28,645 | 0.0% | 0.46% | +39.5% |
| Q2 2021 | $2,682,000 | -39.8% | 28,645 | -40.8% | 0.33% | -42.0% |
| Q1 2021 | $4,455,000 | +149.7% | 48,400 | +98.4% | 0.57% | +131.6% |
| Q4 2020 | $1,784,000 | -37.8% | 24,395 | -33.9% | 0.25% | -53.5% |
| Q3 2020 | $2,868,000 | -58.1% | 36,915 | -70.0% | 0.53% | -62.0% |
| Q2 2020 | $6,848,000 | -2.3% | 123,205 | -47.9% | 1.40% | -39.7% |
| Q1 2020 | $7,010,000 | -26.7% | 236,653 | -10.4% | 2.31% | -8.7% |
| Q4 2019 | $9,558,000 | +50.1% | 264,043 | +12.9% | 2.54% | +22.1% |
| Q3 2019 | $6,368,000 | +28.2% | 233,865 | +13.3% | 2.08% | +28.6% |
| Q2 2019 | $4,968,000 | – | 206,470 | – | 1.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |